ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen - 105 ml
68271002 Viatris Pharma GmbH
Posaconazol Viatris 40 mg/ml, Suspension zum Einnehmen19.07.2021
Generic19.07.2021
Posaconazole (J02AC04) 
WHO-DDD18.07.2026
08.06.105 ml
08.06. 
B  
Yes 
IPCI
513.14Yes
    
10 %574.50
7680682710027Synthetika
  
Composition
posaconazolum 200 mg, acidum citricum monohydricum, natrii dihydrogenocitras anhydricus, natrii benzoas 10 mg, natrii laurilsulfas, simeticonum, methylcellulosum, acidum sorbicum, xanthani gummi, glycerolum, glucosum liquidum 2108.5 mg, E 171, aromatica (Kirschen), aqua purificata ad suspensionem pro 5 ml corresp. natrium 5.91 mg.
Packungsbestandteile
Suspension (oral) 
  
 
Active AgentDose
Posaconazole200mg / 5ml
BAG: Active AgentDose
Posaconazole200 mg
 
Inactive agentsDoseadditional_information
Citric Acid Monohydrate  
Acidum Sorbicum  
Aromatica (Kirschen)  
E 171 color.
Glucosum Liquidum2108.5mg / 5ml 
Glycerol  
Methylcellulosum  
Sodium Benzoate10mg / 5ml 
Natrii Dihydrogenocitras Anhydricus  
Natrii Laurilsulfas  
Simeticone  
Xanthani Gummi  
 
Source
Data was imported : 08.11.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home